Microdosing Mushrooms: Science, Benefits & Risks

Microdosing mushrooms involves taking sub-perceptual amounts of psilocybin-containing fungi to potentially influence cognition, mood, and productivity without hallucinations. Research focuses on serotonin 5-HT2A receptor activity, neuroplasticity, and Default Mode Network modulation. Some observational studies report benefits in focus, creativity, and emotional regulation, but controlled trials show mixed results and strong placebo influence. Safety concerns include tolerance buildup, cardiovascular receptor interactions (5-HT2B), and psychological variability. Legal status remains federally restricted in the U.S., with evolving state-level research frameworks. Scientific consensus emphasizes caution, standardization challenges, and the need for further randomized clinical trials.